Clinical Trials Logo

Filter by:
NCT ID: NCT00901862 Completed - Migraine Clinical Trials

Magnetic Therapy in Migraine Prophylaxis

Start date: March 2007
Phase: Phase 1
Study type: Interventional

Background: The therapy with pulsed electromagnetic fields (PEFs) has been used as a therapeutic modality for at least 40 years. However, their effect in the migraine prophylaxis is unclear. Objectives: Evaluate the prophylactic effectiveness of the therapy with PEFs in the handling of migraines. Methodology: Placebo-controlled, randomized, double-blind, crossed clinical study.

NCT ID: NCT00900887 Completed - Clinical trials for Diabetic Retinopathy

Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema

Start date: April 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy of ocular topic antiinflammatory therapy (sodic nepafenac at 0.1% or ketorolac at 0.5%) to treat center point thickness secondary to selective photocoagulation in diabetics with clinically significant macular edema.

NCT ID: NCT00900731 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

INTENSITY
Start date: June 2009
Phase: Phase 3
Study type: Interventional

This study compared the lung effects of indacaterol to those of tiotropium in patients with moderate to severe chronic obstructive pulmonary disease (COPD) over a 12 week period.

NCT ID: NCT00895895 Terminated - Alzheimer Disease Clinical Trials

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Start date: May 2009
Phase: Phase 2
Study type: Interventional

The study will evaluate the efficacy and safety of an investigational drug called SAM-531 at three dosage levels. Subjects will receive either one of the 3 dosage levels of SAM-531, donepezil or placebo for the first 24 weeks of the study (period I). Subjects who receive placebo for period I will be assigned to receive the highest dose of SAM-531 SAM-531 for the remaining 28 weeks of the study, while subjects who received one of the three SAM-531 dosage levels or donepezil in period I will continue with the same study drug (period II).

NCT ID: NCT00895674 Completed - Clinical trials for Carcinoma, Renal Cell

Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

Start date: July 2006
Phase: N/A
Study type: Observational

Renal cell carcinoma accounts for roughly 3 % of all cancer. It is a rather aggressive cancer type, which means that patients who present with an advanced disease have a rather poor prognosis. When this study has been started the standard therapy for patients has been cytokines, which might be accompanied by significant toxicities or might fail the therapeutic goal. In these cases sorafenib can be a feasible therapeutic option. This non-interventional study has been created and is being conducted to collect clinical data on the patients' therapy with sorafenib in an everyday treatment schedule. The main goal of this study focuses on patient characteristics and tumor status in RCC treated with sorafenib as well as the treatment duration and safety of sorafenib under everyday treatment conditions.

NCT ID: NCT00894790 Terminated - Pain Clinical Trials

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

Start date: November 2009
Phase: Phase 4
Study type: Interventional

This Study Will Evaluate Celecoxib Efficacy And Safety Versus Standard Doses Of Diclofenac In Acute Pain Due To Cervical Injury (Due To A Sprain) Related To A Motor Vehicle Accident

NCT ID: NCT00891202 Active, not recruiting - Clinical trials for Gaucher Disease, Type 1

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)

Start date: November 2009
Phase: Phase 3
Study type: Interventional

This Phase 3 study is designed to confirm the efficacy and safety of eliglustat tartrate (Genz-112638) in participants with Gaucher disease Type 1.

NCT ID: NCT00890825 Completed - Clinical trials for Non Small Cell Lung Cancer

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Start date: April 20, 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy of AZD6244 in combination with docetaxel versus docetaxel alone in patients with KRAS mutation positive locally advanced or metastatic non small cell lung cancer.

NCT ID: NCT00887354 Completed - Osteoporosis Clinical Trials

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

MOVE
Start date: April 2009
Phase: Phase 4
Study type: Interventional

This study will evaluate whether teriparatide is superior to the active comparator in the change from baseline of lumbar spine BMD (bone mineral density) in men and postmenopausal women with low bone mass and a recent pertrochanteric hip fracture.

NCT ID: NCT00886405 Recruiting - Clinical trials for Locally Advanced Non Small-Cell Lung Canger

Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer

Start date: July 2006
Phase: Phase 2
Study type: Interventional

Nitroglycerin will increase the effectiveness of treatment with induction chemotherapy and concurrent chemo-radiotherapy by reducing chemo-radio resistance through an increased oxygen pressure in tumoral tissue. The combination treatment of nitroglycerin and chemotherapy will result in longer disease-free and over-all survival in patients with locally advanced NSCLC